Chemicals and minerals maker Tronox now faces a court battle with federal regulators who are suing to block its planned US$1.7 billion acquisition of the titanium dioxide business of Saudi Arabian chemical and mining company Cristal.
The Federal Trade Commission (FTC) is suing based on concerns the transaction would squeeze out competition in the North American market, according to several antitrust experts. But officials at Stamford-based Tronox have vowed to fight the litigation, saying they are committed to fair business practices.
FTC officials assert the acquisition would allow Tronox and another supplier, the Wilmington, Delaware-based Chemours Co, to control the majority of chloride titanium dioxide sales in North America and more than 80% of chloride titanium dioxide manufacturing capacity in the same region. The remaining suppliers would then be more likely to coordinate, according to the FTC.
“It is extremely disappointing that the FTC has taken this unmerited action to try to block a highly synergistic acquisition which will enhance competition in the titanium dioxide industry and benefit our customers around the world,” said Tronox CEO Jeffry Quinn. “Our combination with Cristal is an important part of our strategy to build a vertically integrated company that will deliver a low-cost, secure supply of titanium dioxide pigment to a global customer base.”
Tronox has also denied that it would try to roll back production after closing the deal. It said it would have “powerful incentives” to run its pigment plants at full capacity, regardless of competitors’ activities, and aim to safely expand production at lower costs.
Full Content: Stamford Advocate
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan